- Novel insights and developments in thrombosis and haemostasis
N. van Royen
- Award date
- 11 May 2017
- Number of pages
- Document type
- PhD thesis
- Faculty of Medicine (AMC-UvA)
The first part of this thesis focuses on direct oral anticoagulants (DOACs), a new class of antithrombotic agents which can be prescribed in a stable dosage, unlike their predecessors the Vitamin K antagonists (VKA). In healthy volunteers, prothrombin complex concentrate completely reversed the anticoagulant effect of DOAC rivaroxaban as assessed by coagulation assays, but not of dabigatran. Also, a post-hoc analysis showed evidence that major bleeding under treatment with rivaroxaban had a milder clinical presentation versus VKA associated bleeding. Suitable drug-specific antidotes for DOACs therefore do not appear to be necessary.
The second part of this thesis focuses on (the role of ADAMTS13 in) no-reflow.
Percutaneous coronary interventions (PCI) are known to be life-saving for treating acute myocardial infarctions (AMI), but nevertheless approximately 50% of all PCI are followed by no-reflow: a lack of reperfusion of the myocardium. No-reflow is associated with increased mortality and morbidity. Few therapies have shown success in substantially decreasing no-reflow. Unlike common belief that no-reflow is caused by microvascular obstruction of the pericardium, intramyocardial haemorrhage was detected by cardiac MRIs performed on pigs and patients, and using histopathologic findings from pigs with no-reflow. Metalloprotease ADAMTS13 diminishes the thrombotic properties of coagulation protein Von Willebrand Factor (VWF). In a prospective study following patients with AMI, ADAMTS13 levels were lower and VWF levels higher in case of no-reflow. In a porcine AMI model however, recombinant ADAMTS did not decrease damage caused by no-reflow. The alterations of ADAMTS13/VWF levels seem therefore to be compensatory and necessary.
If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library, or send a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible.